In our interpretation of the results, acromegaly was ruled out in 40/42 patients and considered “possible” in only 2/42 (with persistently elevated IGF-1 and microadenoma detected by MRI, but with GH suppression and without clinical or laboratory progression). The gene discussed is IGF1; the disease is acromegaly.